Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial
Byrd, John C, Hillmen, Peter, Ghia, Paolo, Kater, Arnon P, Chanan-Khan, Asher, Furman, Richard R, O'Brien, Susan, Yenerel, Mustafa Nuri, Illés, Arpad, Kay, Neil, Garcia-Marco, Jose A, Mato, Anthony, Pinilla-Ibarz, Javier, Seymour, John F, Lepretre, Stephane, Stilgenbauer, Stephan, Robak, Tadeusz, Rothbaum, Wayne, Izumi, Raquel, Hamdy, Ahmed, Patel, Priti, Higgins, Kara, Sohoni, Sophia, Jurczak, Wojciech
Published in Journal of clinical oncology (01.11.2021)
Published in Journal of clinical oncology (01.11.2021)
Get full text
Journal Article
The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL
Flinn, Ian W., Hillmen, Peter, Montillo, Marco, Nagy, Zsolt, Illés, Árpád, Etienne, Gabriel, Delgado, Julio, Kuss, Bryone J., Tam, Constantine S., Gasztonyi, Zoltán, Offner, Fritz, Lunin, Scott, Bosch, Francesco, Davids, Matthew S., Lamanna, Nicole, Jaeger, Ulrich, Ghia, Paolo, Cymbalista, Florence, Portell, Craig A., Skarbnik, Alan P., Cashen, Amanda F., Weaver, David T., Kelly, Virginia M., Turnbull, Barry, Stilgenbauer, Stephan
Published in Blood (06.12.2018)
Published in Blood (06.12.2018)
Get full text
Journal Article
A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma
Morschhauser, Franck, Feugier, Pierre, Flinn, Ian W., Gasiorowski, Robin, Greil, Richard, Illés, Árpád, Johnson, Nathalie A., Larouche, Jean-François, Lugtenburg, Pieternella J., Patti, Caterina, Salles, Gilles A., Trněný, Marek, de Vos, Sven, Mir, Farheen, Samineni, Divya, Kim, Su Y., Jiang, Yanwen, Punnoose, Elizabeth, Sinha, Arijit, Clark, Emma, Spielewoy, Nathalie, Humphrey, Kathryn, Bazeos, Alexandra, Zelenetz, Andrew D.
Published in Blood (04.02.2021)
Published in Blood (04.02.2021)
Get full text
Journal Article
Clinical and biological prognostic factors in follicular lymphoma patients
Jóna, Ádám, Kenyeres, Anna, Barna, Sándor, Illés, Árpád, Simon, Zsófia
Published in PloS one (04.08.2022)
Published in PloS one (04.08.2022)
Get full text
Journal Article
Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial
Zelenetz, Andrew D, Prof, Barrientos, Jacqueline C, MD, Brown, Jennifer R, MD, Coiffier, Bertrand, Prof, Delgado, Julio, MD, Egyed, Miklós, Prof, Ghia, Paolo, MD, Illés, Árpád, Prof, Jurczak, Wojciech, MD, Marlton, Paula, MBBS, Montillo, Marco, MD, Morschhauser, Franck, Prof, Pristupa, Alexander S, MD, Robak, Tadeusz, Prof, Sharman, Jeff P, MD, Simpson, David, MBChB, Smolej, Lukáš, MD, Tausch, Eugen, MD, Adewoye, Adeboye H, MD, Dreiling, Lyndah K, MD, Kim, Yeonhee, PhD, Stilgenbauer, Stephan, Prof, Hillmen, Peter, Prof
Published in The lancet oncology (01.03.2017)
Published in The lancet oncology (01.03.2017)
Get full text
Journal Article
Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial
Montillo, Marco, Illés, Árpád, Robak, Tadeusz, Pristupa, Alexander S, Wach, Malgorzata, Egyed, Miklós, Delgado, Julio, Jurczak, Wojciech, Morschhauser, Franck, Schuh, Anna, Eradat, Herbert, Shreay, Sanatan, Barrientos, Jacqueline C, Zelenetz, Andrew D
Published in Health and quality of life outcomes (15.11.2019)
Published in Health and quality of life outcomes (15.11.2019)
Get full text
Journal Article
Age and lymphocyte/monocyte ratio as prognostic factors for autologous transplantation in the treatment of patients with follicular lymphoma
Kenyeres, Anna, Kiss, Evelin, Simon, Zsófia, Illés, Árpád, Jóna, Ádám
Published in Journal of international medical research (01.02.2024)
Published in Journal of international medical research (01.02.2024)
Get full text
Journal Article
The impact of autoimmune cytopenias on the clinical course and survival of Hodgkin lymphoma
Pinczés, László Imre, Szabó, Roxána, Miltényi, Zsófia, Illés, Árpád
Published in International journal of hematology (01.02.2021)
Published in International journal of hematology (01.02.2021)
Get full text
Journal Article
Brentuximab vedotin with chemotherapy for stage III/IV classical Hodgkin lymphoma: 3-year update of the ECHELON-1 study
Straus, David J., Długosz-Danecka, Monika, Alekseev, Sergey, Illés, Árpád, Picardi, Marco, Lech-Maranda, Ewa, Feldman, Tatyana, Smolewski, Piotr, Savage, Kerry J., Bartlett, Nancy L., Walewski, Jan, Ramchandren, Radhakrishnan, Zinzani, Pier Luigi, Hutchings, Martin, Connors, Joseph M., Radford, John, Munoz, Javier, Kim, Won Seog, Advani, Ranjana, Ansell, Stephen M., Younes, Anas, Miao, Harry, Liu, Rachael, Fenton, Keenan, Forero-Torres, Andres, Gallamini, Andrea
Published in Blood (05.03.2020)
Published in Blood (05.03.2020)
Get full text
Journal Article
Diagnostic challenges in patients with Castleman disease, a single center experience from Hungary
Brúgós, Boglárka, Simon, Zsófia, Méhes, Gábor, Illés, Árpád, Pfliegler, György
Published in Pathology oncology research (26.08.2024)
Published in Pathology oncology research (26.08.2024)
Get full text
Journal Article
Assessment of cognitive function in long-term Hodgkin lymphoma survivors, results based on data from a major treatment center in Hungary
Magyari, Ferenc, Virga, István, Simon, Zsófia, Miltényi, Zsófia, Illés, Anna, Kósa, Karolina, Ivánka, Tibor, Berecz, Roland, Égerházi, Anikó, Illés, Árpád
Published in Supportive care in cancer (01.06.2022)
Published in Supportive care in cancer (01.06.2022)
Get full text
Journal Article
Early administration of remdesivir plus convalescent plasma therapy is effective to treat COVID-19 pneumonia in B-cell depleted patients with hematological malignancies
Magyari, Ferenc, Pinczés, László Imre, Páyer, Edit, Farkas, Katalin, Ujfalusi, Szilvia, Diószegi, Ágnes, Sik, Máté, Simon, Zsófia, Nagy, Gergely, Hevessy, Zsuzsanna, Nagy, Béla, Illés, Árpád
Published in Annals of hematology (01.10.2022)
Published in Annals of hematology (01.10.2022)
Get full text
Journal Article
Acalabrutinib Versus Investigator's Choice in Relapsed/Refractory Chronic Lymphocytic Leukemia: Final ASCEND Trial Results
Ghia, Paolo, Pluta, Andrzej, Wach, Małgorzata, Lysak, Daniel, Šimkovič, Martin, Kriachok, Iryna, Illés, Árpád, Serna, Javier, Dolan, Sean, Campbell, Philip, Musuraca, Gerardo, Jacob, Abraham, Avery, Eric J., Lee, Jae Hoon, Usenko, Ganna, Wang, Min Hui, Yu, Ting, Jurczak, Wojciech
Published in HemaSphere (01.12.2022)
Published in HemaSphere (01.12.2022)
Get full text
Journal Article
Efficacy and safety of oral panobinostat plus subcutaneous bortezomib and oral dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma (PANORAMA 3): an open-label, randomised, phase 2 study
Laubach, Jacob P, Schjesvold, Fredrik, Mariz, Mário, Dimopoulos, Meletios A, Lech-Maranda, Ewa, Spicka, Ivan, Hungria, Vania T M, Shelekhova, Tatiana, Abdo, Andre, Jacobasch, Lutz, Polprasert, Chantana, Hájek, Roman, Illés, Árpád, Wróbel, Tomasz, Sureda, Anna, Beksac, Meral, Gonçalves, Iara Z, Bladé, Joan, Rajkumar, S Vincent, Chari, Ajai, Lonial, Sagar, Spencer, Andrew, Maison-Blanche, Pierre, Moreau, Philippe, San-Miguel, Jesus F, Richardson, Paul G
Published in The lancet oncology (01.01.2021)
Published in The lancet oncology (01.01.2021)
Get full text
Journal Article